BRIDGEBIO PHARMA INC's ticker is and the CUSIP is 10806XAB8. A total of 39 filers reported holding BRIDGEBIO PHARMA INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,927,952 | +43.2% | 18,640,000 | +16.8% | 0.01% | +66.7% |
| Q2 2023 | $12,516,351 | +21.7% | 15,957,000 | +16.0% | 0.00% | 0.0% |
| Q1 2023 | $10,282,944 | +112.8% | 13,757,000 | +13.2% | 0.00% | +200.0% |
| Q4 2022 | $4,832,408 | -32.4% | 12,157,000 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $7,149,000 | +30.7% | 12,157,000 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $5,470,000 | -29.3% | 12,157,000 | -7.6% | 0.00% | 0.0% |
| Q1 2022 | $7,733,000 | -27.6% | 13,157,000 | -10.2% | 0.00% | -33.3% |
| Q4 2021 | $10,681,000 | +7.9% | 14,656,000 | +104.8% | 0.00% | +50.0% |
| Q3 2021 | $9,897,000 | -60.1% | 7,156,000 | -52.8% | 0.00% | -60.0% |
| Q2 2021 | $24,785,000 | +68.8% | 15,156,000 | +71.4% | 0.01% | +66.7% |
| Q1 2021 | $14,685,000 | – | 8,845,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRAIDWELL LP | 141,500,000 | $63,675,000 | 2.13% |
| ARISTEIA CAPITAL, L.L.C. | 156,841,000 | $70,578,450 | 1.41% |
| Affinity Asset Advisors, LLC | 7,500,000 | $3,410,048 | 1.34% |
| CONTRARIAN CAPITAL MANAGEMENT, L.L.C. | 8,500,000 | $3,782,500 | 0.94% |
| TFG Asset Management GP Ltd | 10,000,000 | $4,623,611 | 0.66% |
| Context Capital Management, LLC | 17,035 | $7,890 | 0.58% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 47,329,000 | $18,813 | 0.52% |
| SILVERBACK ASSET MANAGEMENT LLC | 5,000,000 | $2,287,850 | 0.32% |
| MACKAY SHIELDS LLC | 14,611,000 | $6,574,950 | 0.17% |
| Ionic Capital Management LLC | 1,400,000 | $644,740 | 0.15% |